Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques Galipeau

Showing results (31-40 of 193) with videos related to

Pageof 20
Sort By:
BMC Immunology|December 18, 2015
Mesenchymal stromal cells to modulate immune reconstitution early post-hematopoietic cell transplantationElizabeth O Stenger, Lakshmanan Krishnamurti, Jacques Galipeau
Cytotherapy|February 1, 2025
Sickle cell disease gene therapy drug expenses and reimbursement: a litmus test for commercial pricing strategy and patient access for curative therapiesBambi J Grilley, Ashley Hume, Jacques Galipeau
Blood|April 30, 2011
Inhibition of cellular senescence by developmentally regulated FGF receptors in mesenchymal stem cellsDaniel L Coutu, Moïra François, Jacques Galipeau
World Journal of Gastroenterology|May 7, 2015
Challenges in animal modelling of mesenchymal stromal cell therapy for inflammatory bowel diseaseRaghavan Chinnadurai, Spencer Ng, Vijayakumar Velu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 29, 2004
Human-compatible collagen matrix for prolonged and reversible systemic delivery of erythropoietin in mice from gene-modified marrow stromal cellsNicoletta Eliopoulos, Laurence Lejeune, Daniel Martineau, et al.
Cytotherapy|February 19, 2020
Improving mesenchymal stem/stromal cell potency and survival: Proceedings from the International Society of Cell Therapy (ISCT) MSC preconference held in May 2018, Palais des Congrès de Montréal, Organized by the ISCT MSC Scientific CommitteeJan A Nolta, Jacques Galipeau, Donald G Phinney
Frontiers in Bioscience (Elite Edition)|December 29, 2011
The immune plasticity of mesenchymal stromal cells from mice and men: concordances and discrepanciesRaphaelle Romieu-Mourez, Daniel L Coutu, Jacques Galipeau
Human Gene Therapy|June 24, 2004
Marrow stromal cells for interleukin-2 delivery in cancer immunotherapyJohn Stagg, Laurence Lejeune, André Paquin, et al.
Journal of Cellular Biochemistry|August 15, 2009
Three-dimensional porous scaffolds at the crossroads of tissue engineering and cell-based gene therapyDaniel L Coutu, Azizeh-Mitra Yousefi, Jacques Galipeau
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 16, 2009
Allogeneic mesenchymal stem cells for treatment of experimental autoimmune encephalomyelitisMoutih Rafei, Elena Birman, Kathy Forner, et al.
Pageof 20

Showing results (31-40 of 193) with videos related to

Sort By:
Pageof 20
BMC Immunology|December 18, 2015
Mesenchymal stromal cells to modulate immune reconstitution early post-hematopoietic cell transplantationElizabeth O Stenger, Lakshmanan Krishnamurti, Jacques Galipeau
Cytotherapy|February 1, 2025
Sickle cell disease gene therapy drug expenses and reimbursement: a litmus test for commercial pricing strategy and patient access for curative therapiesBambi J Grilley, Ashley Hume, Jacques Galipeau
Blood|April 30, 2011
Inhibition of cellular senescence by developmentally regulated FGF receptors in mesenchymal stem cellsDaniel L Coutu, Moïra François, Jacques Galipeau
World Journal of Gastroenterology|May 7, 2015
Challenges in animal modelling of mesenchymal stromal cell therapy for inflammatory bowel diseaseRaghavan Chinnadurai, Spencer Ng, Vijayakumar Velu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 29, 2004
Human-compatible collagen matrix for prolonged and reversible systemic delivery of erythropoietin in mice from gene-modified marrow stromal cellsNicoletta Eliopoulos, Laurence Lejeune, Daniel Martineau, et al.
Cytotherapy|February 19, 2020
Improving mesenchymal stem/stromal cell potency and survival: Proceedings from the International Society of Cell Therapy (ISCT) MSC preconference held in May 2018, Palais des Congrès de Montréal, Organized by the ISCT MSC Scientific CommitteeJan A Nolta, Jacques Galipeau, Donald G Phinney
Frontiers in Bioscience (Elite Edition)|December 29, 2011
The immune plasticity of mesenchymal stromal cells from mice and men: concordances and discrepanciesRaphaelle Romieu-Mourez, Daniel L Coutu, Jacques Galipeau
Human Gene Therapy|June 24, 2004
Marrow stromal cells for interleukin-2 delivery in cancer immunotherapyJohn Stagg, Laurence Lejeune, André Paquin, et al.
Journal of Cellular Biochemistry|August 15, 2009
Three-dimensional porous scaffolds at the crossroads of tissue engineering and cell-based gene therapyDaniel L Coutu, Azizeh-Mitra Yousefi, Jacques Galipeau
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 16, 2009
Allogeneic mesenchymal stem cells for treatment of experimental autoimmune encephalomyelitisMoutih Rafei, Elena Birman, Kathy Forner, et al.
Pageof 20